Bone graft materials and the three "osteo-" properties
Autograft, allograft, xenograft, and alloplast — what each one actually does, judged against the same yardstick: is it osteogenic, osteoinductive, or osteoconductive, and how fast does it resorb?
Use: Basic-science referenceYardstick: The three "osteo-" propertiesGold standard: Autograft
01 — Concepts
The four graft categories
First, the vocabulary. Osteogenic = the graft itself contains living bone-forming cells. Osteoinductive = it supplies signals (e.g. BMPs) that recruit host cells to differentiate into bone. Osteoconductive = it is a passive scaffold that host bone grows along. Only autograft delivers all three.
Tap a graft category to see its properties, resorption & handling
Select a category to expand its biological mechanism, typical resorption behavior, and practical handling notes. Many real-world cases blend materials (e.g. autograft + xenograft) to combine biology with volume stability.
Tap a graft type. Remember the trade-off: more biological activity usually means faster, less predictable resorption.
Which graft material do you want to explore?
AUTOGRAFT
Patient's own bone
All three osteo- properties.
ALLOGRAFT
FDBA / DFDBA
Conductive and/or inductive.
XENOGRAFT
Bovine bone mineral
Conductive, slow resorption.
ALLOPLAST
β-TCP / HA / glass
Synthetic, conductive.
▾
03 — Quick Reference
Material, mechanism, resorption rate, and notes
A side-by-side comparison. "Mechanism" lists which of the three properties the material reliably contributes; resorption behavior drives whether the graft is replaced by host bone or persists as a scaffold.
Durable scaffold; bioactive glass also bonds to bone
Reference
Sources & clinical disclaimer
For licensed clinicians — educational use only. This page summarizes published basic science and is not a substitute for individual clinical judgment, examination, or the standard of care in your jurisdiction. Material selection depends on defect type, goals, and host factors — follow manufacturer instructions and applicable tissue-bank regulations.
Sheikh Z, Hamdan N, Ikeda Y, Grynpas M, Ganss B, Glogauer M. Natural graft tissues and synthetic biomaterials for periodontal and alveolar bone reconstructive applications. Biomater Res. 2017;21:9.
Jung RE, Fenner N, Hämmerle CHF, Zitzmann NU. Long-term outcome of implants placed with guided bone regeneration using deproteinized bovine bone mineral (Bio-Oss) and a collagen membrane (10-year results). Clin Oral Implants Res. 2013;24(10):1065–1073.
Aghaloo TL, Moy PK. Which hard tissue augmentation techniques are the most successful in furnishing bony support for implant placement? Int J Oral Maxillofac Implants. 2007;22(Suppl):49–70.
Last reviewed: June 2026 · Next review due: June 2027 · Version 1.0
Self-Test
Self-Test
Switch between board-style single-best-answer questions and oral-defense prompts. Commit to an answer before revealing.
1. Which graft material is the only one that is simultaneously osteogenic, osteoinductive, and osteoconductive?
A is correct. Only autograft delivers all three: living osteoblasts/progenitors (osteogenic), BMPs and matrix proteins (osteoinductive), and a mineral/collagen scaffold (osteoconductive) — hence the gold standard. Allografts may be inductive and/or conductive but are not osteogenic; xenograft and alloplast are conductive only.
2. A demineralized freeze-dried bone allograft (DFDBA) is considered osteoinductive primarily because demineralization:
B is correct. Acid demineralization of FDBA removes the mineral phase and exposes matrix BMPs, conferring osteoinductive potential (potency varies by donor/batch). No allograft is osteogenic — processing kills cells. Mineralized FDBA, by contrast, is primarily an osteoconductive scaffold.
3. For ridge preservation where long-term volume/contour stability is the priority, which material's resorption behavior best matches the goal?
C is correct. Xenograft (DBBM) resorbs slowly/minimally and persists as a space-maintaining scaffold, giving excellent long-term volume stability — ideal for ridge preservation and sinus floor. Autograft, β-TCP, and DFDBA all resorb relatively quickly, which is less reliable for maintaining contour.
4. A surgeon mixes the patient's own bone with deproteinized bovine bone mineral. The biological rationale is best described as:
B is correct. Autograft supplies osteogenic/inductive activity but can resorb quickly and is volume-limited; DBBM is osteoconductive only but slow-resorbing and volume-stable. Blending combines biology with a durable scaffold — a common clinical strategy. The xenograft is not osteogenic or inductive, and the two do not both resorb rapidly.
1. Define osteogenic, osteoinductive, and osteoconductive, and classify autograft, allograft, xenograft, and alloplast against those three properties.
Model answer. Osteogenic means the graft itself contains living bone-forming cells (osteoblasts/progenitors) that directly form bone. Osteoinductive means it supplies signals — notably BMPs and matrix proteins — that recruit host cells to differentiate into bone. Osteoconductive means it is a passive scaffold that host bone grows along. By category: autograft is all three (the gold standard); allograft is osteoinductive and/or osteoconductive but not osteogenic — FDBA is mineralized and primarily conductive, while DFDBA is demineralized to expose BMPs and is inductive; xenograft (DBBM) is osteoconductive only; alloplast (β-TCP, HA, bioactive glass) is osteoconductive only.
Examiner follow-ups:
Why is no allograft osteogenic?
What makes DFDBA inductive but FDBA not?
Which property is lost first during processing and why?
2. Explain the trade-off between biological activity and resorption rate across the graft categories, and how it guides material choice.
Model answer. As a rule, the more biologically active a graft, the faster and less predictably it resorbs. Autograft is maximally active but can resorb quickly, risking volume loss; DFDBA is inductive and resorbs faster than mineralized FDBA; β-TCP is conductive and resorbs relatively fast (designed to be replaced as bone forms); whereas xenograft (DBBM) and hydroxyapatite are conductive but slow/near non-resorbable, persisting as scaffolds with excellent volume stability. So I match material to goal: where rapid new bone formation matters, lean on autograft/inductive materials; where maintaining contour over time matters (ridge preservation, sinus), use a slow-resorbing scaffold; and frequently I combine them — autograft plus DBBM — to get both biology and stability.
Examiner follow-ups:
Why might a fully resorbing graft be undesirable in a sinus lift?
How does β-TCP differ from HA in resorption?
When would you accept donor-site morbidity for autograft?
3. Defend autograft as the gold standard while acknowledging its limitations, and justify when you would choose an alternative.
Model answer. Autograft is the gold standard because it uniquely combines all three properties — osteogenic, osteoinductive, and osteoconductive — providing living cells, inductive signals, and a scaffold without immunogenicity or disease-transmission risk. Its limitations are real: a second surgical (donor) site with associated morbidity, limited available volume, and fast, sometimes unpredictable resorption. I would choose alternatives when those limitations dominate: allograft or alloplast to avoid a donor site and supply abundant material; xenograft or HA when long-term volume stability outweighs the need for inductive activity; DFDBA when I want inductive signaling without harvesting. In practice I often combine autograft with a slow-resorbing xenograft to capture autograft biology while controlling resorption and preserving contour.
Examiner follow-ups:
What are the main donor-site options and their morbidity?
How does autograft resorption threaten graft volume?
What disease-transmission and immunogenicity issues affect allograft/xenograft?